FDA Drug Moderate Class II Completed

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11

Reported: January 22, 2025 Initiated: December 17, 2024 #D-0202-2025

Product Description

Reason for Recall

Failed Dissolution Specifications:

Details

Recalling Firm: Amerisource Health Services LLC
Units Affected: 2,028 units (cartons of 30 individual unit doses)
Distribution: Nationwide in the USA
Location: Columbus, OH

Frequently Asked Questions

What product was recalled? ▼

glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11. Recalled by Amerisource Health Services LLC. Units affected: 2,028 units (cartons of 30 individual unit doses).

Why was this product recalled? ▼

Failed Dissolution Specifications:

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on January 22, 2025. Severity: Moderate. Recall number: D-0202-2025.